Cannabis Law Report

JANUARY 28, 2022

IIP) (NYSE: IIPR) today announced the tax treatment of its 2021 distributions as follows: Security Description: Common Stock. 01/14/2022. 01/14/2022. allocable to 2022 for federal income tax purposes. SAN DIEGO–(BUSINESS WIRE)– $IIPR #Dividendstocks –Innovative Industrial Properties, Inc. Record Date.

Treatment 52

Treatment Business Cannabis 52

Cannabis Law Report

AUGUST 23, 2021

Phase II clinical trial of the Satipharm CBD capsules showed significantly reduced monthly seizure frequency in the treatment of children suffering from refractory, or treatment-resistant epilepsy when the Satipharm capsules were added to current medications. following 12 weeks of treatment.

Clinical Trials 105

Clinical Trials CBD Epilepsy Treatment 105

CannaMD

MAY 21, 2022

Finding the best treatment for autism has been a lifelong journey for many parents and caretakers. There is currently no known cure for autism, but with medical cannabis, there is hope for safe and effective treatment for autism symptoms.

Treatment 86

Treatment Cannabis Conditions 86

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis. .

Therapy 52

Therapy Treatment Clinical Trials Access 52

Americans for Safe Access

FEBRUARY 3, 2022

On February 2, 2022, Governor Tate Reeves chose to sign SB 2095 into law, making Mississippi the 37th state to adopt medical cannabis laws. On January 26, 2022, the state legislature passed SB 2095, their watered down vision for medical cannabis in Mississippi. . ASA strongly opposes both of these provisions.

Access 251

Access Patients Law Agriculture 251

MMJ Recs

JANUARY 15, 2022

Today, we’ll go through the process of how to get a medical marijuana card in Iowa in 2022. So, how do I get my Iowa MMJ card in 2022? What Are The Qualifying Conditions For A Medical Card In Iowa In 2022? Image by Karolina Grabowska on Pexels : What are the qualifying conditions for a medical card in Iowa in 2022?

Chronic Pain 52

Chronic Pain Dispensary Conditions Programs 52

MMJ Recs

MARCH 15, 2022

If you’ve decided that this is the year that you’d like to try MMJ treatment, read on for our guide on how to get your Missouri MMJ card in 2022 – and all the benefits it can bring you. Image by CBD-Infos-com on Pixabay : How do I get my Missouri MMJ card in 2022? The post How Do I Get My Missouri MMJ Card In 2022?

Conditions 52

Conditions Treatment Epilepsy Dispensary 52

MMJ Recs

JANUARY 25, 2022

So now that medical marijuana is finally available in Ohio, how do you get an Ohio MMJ card in 2022? Not all doctors in Ohio are certified to recommend medical marijuana treatment. How Do I Get My Ohio MMJ Card In 2022? What Are The Qualifying Conditions For A Medical Card In Ohio In 2022? Read on to find out!

Dispensary 52

Dispensary Chronic Pain Programs Treatment 52

TheAnswerPage

AUGUST 26, 2022

This question begins “The Answer of the Day” series on the treatment effects of cannabinoids…. In August 2022, a systematic review and analysis of the use medical cannabinoids for the treatment of various medical indications was published. BMC Med 20, 259 (2022). 0.08] moderate grade). Spanagel, R.

Cannabinoids 52

Cannabinoids Epilepsy Treatment Conditions 52

Cannabis Law Report

SEPTEMBER 15, 2022

A new law passed in July 2022 eliminates the state’s weight-based cannabis cultivation tax to be paid by market growers and created new tax credits for certain cannabis businesses. In 2022, the D.C. Because there was no regular session for the state legislature in 2022, no new state laws related to cannabis were introduced or passed.

Recreational 52

Recreational Legislation Research and Development Retail 52

MMJ Recs

FEBRUARY 4, 2022

If you’ve decided that this is the year you want to start using MMJ to alleviate your symptoms, read on for more information on how to get your Oklahoma MMJ card in 2022. Residents of the state of Oklahoma qualify for an OK MMJ card provided that they have a medical condition that a licensed state physician deems suitable for MMJ treatment.

Conditions 52

Conditions Treatment Edibles Patients 52

Project CBD

JUNE 7, 2023

More recently, a July 2022 paper in BioFactors 8 by Iranian scientists reviewed the antioxidant and immunomodulatory effects of beta-caryophyllene, which was shown to reduce relevant proinflammatory cytokines while increasing anti-inflammatory cytokines. 48,4 (2022): 857-882. Pharmacology vol. 94,1-2 (2014): 1-12. doi:10.1002/biof.1869

Terpenes 227

Terpenes Chronic Pain Cannabinoids Food 227

Veriheal

JULY 9, 2021

For the past 25 years, Desouza has been investigating the world of cannabinoid treatment options. We don’t have any proven treatments for cannabis addiction,” admitted Desouza, whose study is focused on the plant’s suitability for inhibiting cannabis withdrawal symptoms. . Anyone who is keen to partake should call 203-900-4093.

Treatment 52

Treatment Research and Development Consumption Sleep 52

TheAnswerPage

FEBRUARY 26, 2022

Have any states legalized the use of cannabis for medicinal purposes since the start of 2022? states in legalizing marijuana for medical use in February, 2022. Yes, Mississippi joined 36 other U.S.

Treatment 52

Treatment Legislation Conditions Medicine 52

TheAnswerPage

JUNE 12, 2022

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A transdermal gel for regional and systemic delivery of CBD (Zynerba Pharmaceuticals) is in clinical development for treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome, and osteoarthritis.

Epilepsy 52

Epilepsy Topical Safety Treatment 52

TheAnswerPage

AUGUST 27, 2022

“The Answer of the Day” series on the treatment effects of cannabinoids continues… According to randomized controlled trials, which health conditions does dronabinol (Marinol – a synthetic THC product) effectively treat? BMC Med 20, 259 (2022). Spanagel, R. See the Answer.

Chronic Pain 52

Chronic Pain Cannabinoids Treatment THC 52

TheAnswerPage

FEBRUARY 25, 2022

83% of all patients considered marijuana as treatment for cancer related pain and 67% as treatment for cancer related anxiety. About 70% of patients actively undergoing cancer treatment believed marijuana medications would help with symptoms during treatment.” January 2022. ” Levin M, Zhang H, Gupta MK.

Treatment 52

Treatment Therapy Patients Marijuana 52

TheAnswerPage

AUGUST 28, 2022

“The Answer of the Day” series on the treatment effects of cannabinoids continues… According to randomized controlled trials, which health conditions does nabiximols (Sativex – ~50:50 THC:CBD plant-derived product) effectively treat? BMC Med 20, 259 (2022). Spanagel, R. See the Answer.

Chronic Pain 52

Chronic Pain Therapy Sleep Cannabinoids 52

TheAnswerPage

JULY 2, 2022

for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids. for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids. June 21, 2022. ” … “Safety and effectiveness of nalmefene hydrochloride injection in pediatric patients have NOT been established.”

Treatment 52

Treatment Safety Patients Cannabis 52

Project CBD

APRIL 26, 2023

He had never taken anti-psychotic drugs nor received psychological treatment. Due to its excellent tolerability and promising efficacy … and its innovative new mechanisms of action, we decided to offer a respective treatment with cannabidiol to [the] patient,” they write. Cannabidiol as a potential treatment for psychosis.”

CBD 289

CBD Treatment Cannabinoids Medicine 289

Cannabis Law Report

FEBRUARY 9, 2022

Cybin plans to submit a clinical trial application for a pilot study of CYB004 in the second quarter of calendar year 2022 and expects to initiate the pilot study in the third quarter of calendar year 2022.

Treatment 52

Treatment Clinical Trials Research and Development 52

Cannabis Law Report

OCTOBER 1, 2021

TD-0148A is currently in preclinical pharmacology and other IND-enabling studies and in 2022, BetterLife will file its IND and start Phases 1 and 2 in healthy subjects for major depressive disorder. BetterLife is already in advanced stages of GMP manufacturing TD-0148A and initiated the necessary preclinical IND-enabling studies for TD-0148A.

Treatment 52

Treatment Conditions Media 52

TheAnswerPage

JANUARY 23, 2022

Did the FDA recently approve an investigational new drug (IND) application for a clinical trial investigating a CBD product as an adjunctive treatment for opioid use disorder (OUD)? Pharmacy Times, Jan 6, 2022. The product is a CBD soft gel capsule with 100mg/capsule. FDA Approves IND Application for CBD Product Nantheia ATL5.

Clinical Trials 52

Clinical Trials CBD Treatment 52

TheAnswerPage

JULY 3, 2022

for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids. June 21, 2022. In many cases, these effects appear to be the result of abrupt reversal of opioid effects.” ” Purdue Pharma Introduces Nalmefene HCl Injection, 2mg/2mL (1mg/1mL) in the U.S. See the Answer.

Treatment 52

Treatment Cannabis 52

TheAnswerPage

MAY 22, 2022

According to this document, are there any blood tests that should be performed prior to initiating treatment with Epidiolex? Yes, it is suggested that serum transaminases (ALT and AST) and total bilirubin levels be obtained prior to starting treatment with Epidiolex.

Treatment 98

Treatment Patients CBD 98

TheAnswerPage

JULY 4, 2022

for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids. June 21, 2022. Imprudent use or excessive doses of opioid antagonists in the postoperative setting has been associated with hypertension, tachycardia, and excessive mortality in patients at high risk for cardiovascular complications.”

Patients 52

Patients Treatment 52

Cannabis Law Report

MAY 18, 2022

Wednesday 18 May 2022. It will consider the potential harms and benefits of controlled drugs, and the treatments available for drug addiction and whether they are adequate. The Committee takes evidence from members of the Advisory Council on the Misuse of Drugs, which advises the Government on drugs policy, and other academic experts.

Policy 52

Policy Treatment Legislation Access 52

Cannabis Law Report

JULY 13, 2022

Here’s what they posted 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. Compliance Priority. Deter and address the unlawful import, advertising and supply of unapproved therapeutic goods associated with COVID-19.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

TheAnswerPage

APRIL 3, 2022

As a result, tumors from an adult and a child with identical histology often have very different biology, and consequently must be treated differently, and indeed may respond differently to the same treatment.” Pharmaceuticals 2022, 15, 359. ” Malach, M.; Kovalchuk, I.; Kovalchuk, O. link] ph15030359. See the Answer.

Therapy 52

Therapy Research and Development Pharmaceutical Cannabinoids 52

TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Their findings included the following: “The average daily dose ranged between 1 and 50 mg/kg, with treatment length from 3 to 12 months (mean 6.2 12 September 2018.

Epilepsy 72

Epilepsy Extraction Treatment CBD 72

Cannabis Law Report

DECEMBER 21, 2021

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Leafwell

JANUARY 11, 2022

Only about 37 percent of people afflicted with anxiety receive treatment. According to the Anxiety and Depression Association of America (ADAA), 40 million U.S. adults grapple with anxiety disorders each year. Anxiety disorders are America’s most common mental illness and are deemed highly treatable. The 63 percent of anxiety-plagued.

CBD 63

CBD Treatment Conditions Cannabis 63

TheAnswerPage

MAY 25, 2022

A May 2021 study demonstrated that CBD does not lose its efficacy in controlling seizures over a treatment period of up to 60 months. In addition, other results on the efficacy and tolerability of CBD in the treatment of refractory epilepsies, suggest that CBD is an effective, safe, and well-tolerated anti-epileptic drug for long-term use.

Clinical Trials 52

Clinical Trials Epilepsy Treatment CBD 52

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 52

Epilepsy Therapy Extraction Data 52

TheAnswerPage

JULY 18, 2022

In 2017, researchers performed an analysis of observational studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products and reported on the side effects of the CBD products: “The reports of mild (158/216, 76% vs. 148/447, 33%, p. Pamplona F, da Silva L and Coan A.

Epilepsy 52

Epilepsy Therapy Extraction Treatment 52

TheAnswerPage

AUGUST 8, 2022

Currently, CBD-containing gels are being evaluated for the treatment of several pediatric disorders, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. See the Answer.

Epilepsy 59

Epilepsy Topical Treatment CBD 59

Veriheal

JANUARY 12, 2024

In January 2022, a devastating incident shook the U.S. She received asthma treatment, although she had no history of the condition. By January 2022, her respiratory issues had worsened. Do not attempt to self-diagnose or prescribe treatment based on the information provided. cannabis cultivation industry.

Conditions 112

Conditions Cultivation Safety Advocacy 112